Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith L Davis

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Drugs - Real World Outcomes|September 17, 2021
European and US Real-World Treatment Patterns in Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Retrospective Medical Record ReviewRiyaz Shah, Nicolas Girard, Saurabh P Nagar, et al.
Future Oncology (London, England)|August 14, 2020
POLARIS: a prospective, multicenter, noninterventional study assessing palbociclib in hormone receptor-positive advanced breast cancerDebasish Tripathy, Joanne L Blum, Gabrielle B Rocque, et al.
Current Medical Research and Opinion|May 8, 2019
Treatment patterns, survival and economic outcomes in Medicare-enrolled, older patients with HR+/HER2- metastatic breast cancerRavi K Goyal, Gebra Cuyun Carter, Saurabh P Nagar, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|August 7, 2020
Treatment patterns, adverse events, and direct and indirect economic burden in a privately insured population of patients with HR+/HER2- metastatic breast cancer in the United StatesRavi K Goyal, Gebra Cuyun Carter, Saurabh P Nagar, et al.
Cancer|April 15, 2025
Real-world treatment patterns and outcomes with oral azacitidine maintenance therapy in patients with acute myeloid leukemiaBrian Leber, Marcia T Ruiz, Hany Elgendy, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Real-world treatment patterns and survival of patients with BRAF V600-mutated metastatic non-small cell lung cancerLeora Horn, Joshua Bauml, Patrick M Forde, et al.
Breast Cancer Research and Treatment|August 6, 2025
Real-world clinical outcomes associated with first-line palbociclib and aromatase inhibitor therapy among patients with HR+/HER2- advanced breast cancer in EuropeOlga Oikonomidou, Mark J Beresford, Elena Galve-Calvo, et al.
Lung Cancer (Amsterdam, Netherlands)|March 13, 2026
EGFR mutation status, treatment patterns, and outcomes in resectable early-stage non-small cell lung cancer prior to adjuvant EGFR-TKI approval: An international real-world studySteven H Lin, Doreen A Kahangire, Saurabh P Nagar, et al.
Hemasphere|July 11, 2022
A Retrospective Cohort Study of Treatment Outcomes of Adult Patients With Relapsed or Refractory Follicular Lymphoma (ReCORD-FL)Gilles Salles, Stephen J Schuster, Luca Fischer, et al.
Clinical Lung Cancer|September 23, 2023
Improved Survival Outcomes in Patients With MET-Dysregulated Advanced NSCLC Treated With MET Inhibitors: Results of a Multinational Retrospective Chart ReviewJürgen Wolf, Pierre-Jean Souquet, Koichi Goto, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Drugs - Real World Outcomes|September 17, 2021
European and US Real-World Treatment Patterns in Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Retrospective Medical Record ReviewRiyaz Shah, Nicolas Girard, Saurabh P Nagar, et al.
Future Oncology (London, England)|August 14, 2020
POLARIS: a prospective, multicenter, noninterventional study assessing palbociclib in hormone receptor-positive advanced breast cancerDebasish Tripathy, Joanne L Blum, Gabrielle B Rocque, et al.
Current Medical Research and Opinion|May 8, 2019
Treatment patterns, survival and economic outcomes in Medicare-enrolled, older patients with HR+/HER2- metastatic breast cancerRavi K Goyal, Gebra Cuyun Carter, Saurabh P Nagar, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|August 7, 2020
Treatment patterns, adverse events, and direct and indirect economic burden in a privately insured population of patients with HR+/HER2- metastatic breast cancer in the United StatesRavi K Goyal, Gebra Cuyun Carter, Saurabh P Nagar, et al.
Cancer|April 15, 2025
Real-world treatment patterns and outcomes with oral azacitidine maintenance therapy in patients with acute myeloid leukemiaBrian Leber, Marcia T Ruiz, Hany Elgendy, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Real-world treatment patterns and survival of patients with BRAF V600-mutated metastatic non-small cell lung cancerLeora Horn, Joshua Bauml, Patrick M Forde, et al.
Breast Cancer Research and Treatment|August 6, 2025
Real-world clinical outcomes associated with first-line palbociclib and aromatase inhibitor therapy among patients with HR+/HER2- advanced breast cancer in EuropeOlga Oikonomidou, Mark J Beresford, Elena Galve-Calvo, et al.
Lung Cancer (Amsterdam, Netherlands)|March 13, 2026
EGFR mutation status, treatment patterns, and outcomes in resectable early-stage non-small cell lung cancer prior to adjuvant EGFR-TKI approval: An international real-world studySteven H Lin, Doreen A Kahangire, Saurabh P Nagar, et al.
Hemasphere|July 11, 2022
A Retrospective Cohort Study of Treatment Outcomes of Adult Patients With Relapsed or Refractory Follicular Lymphoma (ReCORD-FL)Gilles Salles, Stephen J Schuster, Luca Fischer, et al.
Clinical Lung Cancer|September 23, 2023
Improved Survival Outcomes in Patients With MET-Dysregulated Advanced NSCLC Treated With MET Inhibitors: Results of a Multinational Retrospective Chart ReviewJürgen Wolf, Pierre-Jean Souquet, Koichi Goto, et al.
Pageof 9